IL6 and malaria: HCQ continues to be used in several countries for COVID-19 patients14, and for malaria and for autoimmune diseases such as lupus erythematosus and rheumatoid arthritis both conditions known to also experience high levels of IL-6 along with increased prevalence of QTc prolongation and sudden cardiac death61–63.